Related references
Note: Only part of the references are listed.2′-Deoxyadenosine 5′-diphosphoribose is an endogenous TRPM2 superagonist
Ralf Fliegert et al.
NATURE CHEMICAL BIOLOGY (2017)
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets
Deepak A. Deshpande et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model
Eran Blacher et al.
ANNALS OF NEUROLOGY (2015)
Synthesis of cyclic N1-pentylinosine phosphate, a new structurally reduced cADPR analogue with calcium-mobilizing activity on PC12 cells
Ahmed Mahal et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2015)
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors
Curt D. Haffner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
H. M. Lokhorst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
'Click cyclic ADP-ribose': a neutral second messenger mimic
Joanna M. Swarbrick et al.
CHEMICAL COMMUNICATIONS (2014)
Cyclic Adenosine 5′-Diphosphate Ribose Analogs without a Southern Ribose Inhibit ADP-ribosyl Cyclase-Hydrolase CD38
Joanna M. Swarbrick et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
NAD+ metabolism: A therapeutic target for age-related metabolic disease
Laurent Mouchiroud et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5 '-Diphosphate Ribose Template
Christelle Moreau et al.
PLOS ONE (2013)
Catalysis-Based Inhibitors of the Calcium Signaling Function of CD38
Anna Ka Yee Kwong et al.
BIOCHEMISTRY (2012)
Design, Synthesis and Biological Evaluation of Noncovalent Inhibitors of Human CD38 NADase
Yi Zhou et al.
CHEMMEDCHEM (2012)
Total Synthesis of a Cyclic Adenosine 5′-Diphosphate Ribose Receptor Agonist
Joanna M. Swarbrick et al.
JOURNAL OF ORGANIC CHEMISTRY (2012)
Flavonoids as inhibitors of human CD38
Esther Kellenberger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
CD38 and chronic lymphocytic leukemia: a decade later
Fabio Malavasi et al.
BLOOD (2011)
Synthesis of cyclic adenosine 5 '-diphosphate ribose analogues: a C2 ' endo/syn southern ribose conformation underlies activity at the sea urchin cADPR receptor
Christelle Moreau et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2011)
The Ecto-enzyme CD38 Is a Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Synthase That Couples Receptor Activation to Ca2+ Mobilization from Lysosomes in Pancreatic Acinar Cells
Francois Cosker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
CD38 as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions
Eduardo Nunes Chini
CURRENT PHARMACEUTICAL DESIGN (2009)
Mechanism of Cyclizing NAD to Cyclic ADP-ribose by ADP-ribosyl Cyclase and CD38
Richard Graeff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structural Basis for Enzymatic Evolution from a Dedicated ADP-ribosyl Cyclase to a Multifunctional NAD Hydrolase
Qun Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by ADP-Ribose, the major product generated by the CD38 enzyme reaction
Santiago Partida-Sanchez et al.
JOURNAL OF IMMUNOLOGY (2007)
Catalysis-associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog
Qun Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives
T. Kirchberger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Decreased cADPR and increased NAD+ in the Cd38-/- mouse
Genevieve S. Young et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Regulation of intracellular levels of NAD: A novel role for CD38
Pinar Aksoy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
L-Nucleoside enantiomers as antivirals drugs: A mini-review
Christophe Mathe et al.
ANTIVIRAL RESEARCH (2006)
Rapid synthetic route toward structurally modified derivatives of cyclic adenosine 5′-diphosphate ribose
GK Wagner et al.
JOURNAL OF ORGANIC CHEMISTRY (2005)
A minimal structural analogue of cyclic ADP-ribose -: Synthesis and calcium release activity in mammalian cells
AH Guse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR)
AH Guse
FEBS JOURNAL (2005)
Multiplicity of Ca2+ messengers and Ca2+ stores:: A perspective from cyclic ADP-ribose and NAADP
HC Lee
CURRENT MOLECULAR MEDICINE (2004)
Biochemistry, biology, and pharmacology of cyclic adenosine diphosphoribose (cADPR)
AH Guse
CURRENT MEDICINAL CHEMISTRY (2004)
Synthesis and biological evaluation of novel membrane-permeant cyclic ADP-ribose mimics:: N1-[(5-O-phosphorylethoxy)methyl]-5′-O-phosphorylinosine 5′,5-cyclicpyrophosphate (cIDPRE) and 8-substituted derivatives
XF Gu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Medicinal chemistry and pharmacology of cyclic ADP-ribose
BVL Potter et al.
CURRENT MOLECULAR MEDICINE (2004)
Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.
A Savarino et al.
FASEB JOURNAL (2003)
Novel hydrolysis-resistant analogues of cyclic ADP-ribose: Modification of the northern ribose and calcium release activity
AH Guse et al.
BIOCHEMISTRY (2002)
A novel cycling assay for cellular cADP-ribose with nanomolar sensitivity
R Graeff et al.
BIOCHEMICAL JOURNAL (2002)
Total synthesis of cyclic ADP-carbocyclic-ribose, a stable mimic of Ca2+-mobilizing second messenger cyclic ADP-ribose
S Shuto et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
A covalent intermediate in CD38 is responsible for ADP-ribosylation and cyclization reactions
AA Sauve et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Identification of the enzymatic active site of CD38 by site-directed mutagenesis
C Munshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
